News

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...
The Green Steel Market, valued at USD 7.4 billion in 2024, is expected to reach USD 19.4 billion by 2029, growing at a CAGR ...
United Commercial Bank (UCB) has launched the first open API-based banking system in Bangladesh.  With this initiative, the bank will be able to provide modern, convenient, and technology-driven ...
Belgian pharmaceutical company UCB says it plans to invest $5bn in a US factory to avoid President Trump’s tariffs on the EU.
Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now. On June 12, UCB and Biogen presented ...
United Commercial Bank PLC (UCB) has launched a microservices-based open API banking platform in Bangladesh following an ...
UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...
Amid the threat of pharmaceutical tariffs from President Donald Trump, recent months have seen multibillion-dollar U.S.
Belgium’s largest drugmaker UCB has announced plans for a significant investment in a new, state-of-the-art biologics ...
Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...
Ultimately, Stoke Therapeutics is that classic “intriguing biotech” --hurdling to one of those proverbial “moments of truth” ...
Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...